Sage Rhino Capital’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $267K | Sell |
659
-24
| -4% | -$9.73K | 0.06% | 191 |
|
|
2025
Q1 | $340K | Sell |
683
-4
| -0.6% | -$1.99K | 0.08% | 159 |
|
|
2024
Q4 | $357K | Sell |
687
-5
| -0.7% | -$2.6K | 0.08% | 156 |
|
|
2024
Q3 | $428K | Sell |
692
-2
| -0.3% | -$1.24K | 0.09% | 148 |
|
|
2024
Q2 | $384K | Buy |
694
+14
| +2% | +$7.74K | 0.09% | 147 |
|
|
2024
Q1 | $395K | Buy |
680
+22
| +3% | +$12.8K | 0.09% | 146 |
|
|
2023
Q4 | $349K | Sell |
658
-26
| -4% | -$13.8K | 0.09% | 145 |
|
|
2023
Q3 | $346K | Buy |
684
+6
| +0.9% | +$3.04K | 0.1% | 144 |
|
|
2023
Q2 | $354K | Sell |
678
-45
| -6% | -$23.5K | 0.1% | 143 |
|
|
2023
Q1 | $417K | Buy |
723
+18
| +3% | +$10.4K | 0.12% | 133 |
|
|
2022
Q4 | $388K | Hold |
705
| – | – | 0.12% | 130 |
|
|
2022
Q3 | $358K | Buy |
705
+3
| +0.4% | +$1.52K | 0.14% | 111 |
|
|
2022
Q2 | $381K | Sell |
702
-8
| -1% | -$4.34K | 0.15% | 118 |
|
|
2022
Q1 | $419K | Sell |
710
-3
| -0.4% | -$1.77K | 0.13% | 136 |
|
|
2021
Q4 | $476K | Buy |
713
+7
| +1% | +$4.67K | 0.13% | 126 |
|
|
2021
Q3 | $403K | Buy |
706
+14
| +2% | +$7.99K | 0.12% | 124 |
|
|
2021
Q2 | $349K | Buy |
692
+244
| +54% | +$123K | 0.1% | 138 |
|
|
2021
Q1 | $204K | Sell |
448
-222
| -33% | -$101K | 0.07% | 168 |
|
|
2020
Q4 | $312K | Buy |
670
+2
| +0.3% | +$931 | 0.12% | 123 |
|
|
2020
Q3 | $295K | Buy |
668
+2
| +0.3% | +$883 | 0.14% | 116 |
|
|
2020
Q2 | $241K | Buy |
+666
| New | +$241K | 0.13% | 128 |
|
|
2020
Q1 | – | Sell |
-634
| Closed | -$208K | – | 160 |
|
|
2019
Q4 | $208K | Buy |
+634
| New | +$208K | 0.12% | 139 |
|